These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
259 related articles for article (PubMed ID: 32216005)
61. Visualization of hepatitis B virus entry - novel tools and approaches to directly follow virus entry into hepatocytes. Zhang Z; Zehnder B; Damrau C; Urban S FEBS Lett; 2016 Jul; 590(13):1915-26. PubMed ID: 27149321 [TBL] [Abstract][Full Text] [Related]
62. [Novel vector preS1-tp fusion protein effectively inhibits hepatitis B virus replication and cccDNA synthesis by mediating hepatitis B virus targeting sequence small interfering RNA]. Zeng YL; Gao F; Zhang C; Wei JF; Ma L; Ding GG; Li W; Shang J; Kang Y Zhonghua Gan Zang Bing Za Zhi; 2021 Feb; 29(2):126-132. PubMed ID: 33685080 [No Abstract] [Full Text] [Related]
63. Fungal Secondary Metabolite Exophillic Acid Selectively Inhibits the Entry of Hepatitis B and D Viruses. Kobayashi C; Watanabe Y; Oshima M; Hirose T; Yamasaki M; Iwamoto M; Iwatsuki M; Asami Y; Kuramochi K; Wakae K; Aizaki H; Muramatsu M; Sureau C; Sunazuka T; Watashi K Viruses; 2022 Apr; 14(4):. PubMed ID: 35458494 [TBL] [Abstract][Full Text] [Related]
64. Entry of bovine parainfluenza virus type 3 into MDBK cells occurs via clathrin-mediated endocytosis and macropinocytosis in a acid-dependent manner. Pan W; Hui N; Wang H; He H Vet Microbiol; 2021 Aug; 259():109148. PubMed ID: 34147763 [TBL] [Abstract][Full Text] [Related]
65. Development of a cell-based assay to identify hepatitis B virus entry inhibitors targeting the sodium taurocholate cotransporting polypeptide. Miyakawa K; Matsunaga S; Yamaoka Y; Dairaku M; Fukano K; Kimura H; Chimuro T; Nishitsuji H; Watashi K; Shimotohno K; Wakita T; Ryo A Oncotarget; 2018 May; 9(34):23681-23694. PubMed ID: 29805766 [TBL] [Abstract][Full Text] [Related]
66. Retrotransposon elements among initial sites of hepatitis B virus integration into human genome in the HepG2-NTCP cell infection model. Chauhan R; Shimizu Y; Watashi K; Wakita T; Fukasawa M; Michalak TI Cancer Genet; 2019 Jun; 235-236():39-56. PubMed ID: 31064734 [TBL] [Abstract][Full Text] [Related]
67. The kinesin KIF4 mediates HBV/HDV entry through the regulation of surface NTCP localization and can be targeted by RXR agonists in vitro. Gad SA; Sugiyama M; Tsuge M; Wakae K; Fukano K; Oshima M; Sureau C; Watanabe N; Kato T; Murayama A; Li Y; Shoji I; Shimotohno K; Chayama K; Muramatsu M; Wakita T; Nozaki T; Aly HH PLoS Pathog; 2022 Mar; 18(3):e1009983. PubMed ID: 35312737 [TBL] [Abstract][Full Text] [Related]
68. Exploring the tolerable region for HiBiT tag insertion in the hepatitis B virus genome. Murayama A; Igarashi H; Yamada N; Aly HH; Toyama M; Isogawa M; Shimakami T; Kato T mSphere; 2024 Oct; 9(10):e0051824. PubMed ID: 39345122 [TBL] [Abstract][Full Text] [Related]
69. Elucidation of the early infection machinery of hepatitis B virus by using bio-nanocapsule. Liu Q; Somiya M; Kuroda S World J Gastroenterol; 2016 Oct; 22(38):8489-8496. PubMed ID: 27784961 [TBL] [Abstract][Full Text] [Related]
70. In Vitro Infection with Hepatitis B Virus Using Differentiated Human Serum Culture of Huh7.5-NTCP Cells without Requiring Dimethyl Sulfoxide. Le C; Sirajee R; Steenbergen R; Joyce MA; Addison WR; Tyrrell DL Viruses; 2021 Jan; 13(1):. PubMed ID: 33445753 [TBL] [Abstract][Full Text] [Related]
71. Silencing Retinoid X Receptor Alpha Expression Enhances Early-Stage Hepatitis B Virus Infection In Cell Cultures. Song M; Sun Y; Tian J; He W; Xu G; Jing Z; Li W J Virol; 2018 Apr; 92(8):. PubMed ID: 29437960 [TBL] [Abstract][Full Text] [Related]
72. Entry of Challenge Virus Standard (CVS) -11 into N2a cells via a clathrin-mediated, cholesterol-, dynamin-, pH-dependent endocytic pathway. Gao J; Wang X; Zhao M; Liu E; Duan M; Guan Z; Guo Y; Zhang M Virol J; 2019 Jun; 16(1):80. PubMed ID: 31196105 [TBL] [Abstract][Full Text] [Related]
73. Sodium taurocholate cotransporting polypeptide is the limiting host factor of hepatitis B virus infection in macaque and pig hepatocytes. Lempp FA; Wiedtke E; Qu B; Roques P; Chemin I; Vondran FWR; Le Grand R; Grimm D; Urban S Hepatology; 2017 Sep; 66(3):703-716. PubMed ID: 28195359 [TBL] [Abstract][Full Text] [Related]
74. Early events in hepatitis B virus infection: From the cell surface to the nucleus. Hayes CN; Zhang Y; Makokha GN; Hasan MZ; Omokoko MD; Chayama K J Gastroenterol Hepatol; 2016 Feb; 31(2):302-9. PubMed ID: 26414381 [TBL] [Abstract][Full Text] [Related]
76. Bovine Parainfluenza Virus Type 3 (BPIV3) Enters HeLa Cells via Clathrin-Mediated Endocytosis in a Cholesterol- and Dynamin-Dependent Manner. Pan W; Nie H; Wang H; He H Viruses; 2021 May; 13(6):. PubMed ID: 34072688 [TBL] [Abstract][Full Text] [Related]
77. Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus. Yan H; Zhong G; Xu G; He W; Jing Z; Gao Z; Huang Y; Qi Y; Peng B; Wang H; Fu L; Song M; Chen P; Gao W; Ren B; Sun Y; Cai T; Feng X; Sui J; Li W Elife; 2012 Nov; 3():. PubMed ID: 25409679 [TBL] [Abstract][Full Text] [Related]
78. The FDA-approved drug irbesartan inhibits HBV-infection in HepG2 cells stably expressing sodium taurocholate co-transporting polypeptide. Ko C; Park WJ; Park S; Kim S; Windisch MP; Ryu WS Antivir Ther; 2015; 20(8):835-42. PubMed ID: 25929767 [TBL] [Abstract][Full Text] [Related]
79. Neuropilin-1 is a novel host factor modulating the entry of hepatitis B virus. Yu H; Ren J; Deng H; Li L; Zhang Z; Cheng S; Guo Z; Huang A; Dang Y; Song K; Wu D; Yao X; Qin Y; Yang Z; Xu K; He X; Chen J J Hepatol; 2025 Jan; 82(1):37-50. PubMed ID: 38960374 [TBL] [Abstract][Full Text] [Related]